Experience

Aescape Acquires Exclusive Rights to Tom Brady’s Science-Backed Longevity Protocols

September 23, 2025

Cooley advised Aescape, the leader in artificial intelligence-powered recovery technology, on its acquisition of the exclusive rights to Tom Brady’s recovery and longevity protocols.

Read more

Related contacts

Mike Lincoln
Vice Chair, Reston
Danielle Gershowitz
Partner, New York
Alex Abelson
Associate, New York
Adam Chase
Partner, Washington, DC
Nyron J. Persaud
Partner, New York
Rhea George
Associate, New York
Stephanie Gentile
Partner, New York
Joshua Holleman
Partner, Washington, DC
Wesley Dietrich
Associate, Washington, DC
Caolinn Mejza
Associate, New York
Talya Whyte
Associate, New York

Related Practices & Industries

AllRock Bio Closes $50 Million Series A

September 16, 2025

Cooley advised AllRock Bio, a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases, on its $50 million Series A financing to advance AllRock’s lead molecule, ROC-101, a first-in-class, oral pan-rho-associated protein kinase inhibitor to treat pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.

Read more

Related contacts

Ryan Sansom
Partner, Boston
Barry Kuang
Associate, Boston
Danbi Kim
Associate, Boston
Christophe Beauduin
Partner, New York
Megan Boss
Senior Paralegal , Boston
Stephanie Gentile
Partner, New York

Related Practices & Industries

LB Pharmaceuticals Announces $285 Million Upsized IPO

September 12, 2025

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Minkyu Park
Special Counsel, New York
Denny Xu
Associate, Boston
Danbi Kim
Associate, Boston
Ariane A. Andrade
Partner, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Karun Ahuja
Special Counsel, Chicago
Brandon Lefebvre
Quantitative Analyst, Boston
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Gerard O'Shea
Partner, New York
David Peinsipp
Partner, San Francisco
Ryan Vann
Partner, Chicago
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jessica Koffel
Special Counsel, Brussels
Rebecca Ross
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Chelsea Braun
Associate, Boston
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Vince Flynn
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Brenna McGuire
Associate, Washington, DC
Sarah Miller
Associate, New York
Jayne M. Munger
Associate, New York
Miles Patton
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Cathy Rude
Paralegal Specialist, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Forward Industries Announces $1.65 Billion PIPE Offering

September 11, 2025

Cooley advised Jump Crypto as a sponsor in connection with $1.65 billion in cash and stablecoin commitments for a private investment in public equity (PIPE) offering by Forward Industries, a global design company serving top-tier medical and technology companies, to initiate a Solana-focused digital asset treasury strategy, aligning Forward Industries with the fast-growing Solana ecosystem.

Read more

Related contacts

Yvan-Claude Pierre
Partner, New York
Daniel I. Goldberg
Partner, New York
Derek Colla
Partner, Miami
Stephanie Gentile
Partner, New York
Minkyu Park
Special Counsel, New York
David Peinsipp
Partner, San Francisco
Samuel Paullin
Associate, Chicago
Leah Duncan
Associate, Chicago
Benjamin Shulman
Associate, New York
Todd Gluth
Partner, San Diego

Related Practices & Industries

Tourmaline Bio Enters Into Agreement to be Acquired by Novartis

September 9, 2025

Read more

Related contacts

Bill Sorabella
Partner, New York
Brandon W. Fenn
Partner, New York
Natalie D. Vernon
Associate, Colorado
Sangitha Palaniappa
Associate, Palo Alto
Katherine Denby
Special Counsel, Washington, DC
Pengli Li
Associate, Boston
Nyron J. Persaud
Partner, New York
Megan Browdie
Partner, Washington, DC
Anne Luquette
Associate, San Francisco
Brittany Sanok
Associate, New York
Annie Froehlich
Partner, Washington, DC
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Carly Mitchell
Partner, Washington, DC
Phil Mitchell
Partner, New York
Ryan Montgomery
Partner, Boston
John Paul Oleksiuk
Partner, New York
Alan W. Tamarelli
Partner, New York
Dr. Michael Tuscan
Partner, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
J. Brian Stalter
Special Counsel, New York

Related Practices & Industries

View more

Admissions and credentials

New York

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.